Overcoming the therapeutic limitations of EZH2 inhibitors in Burkitt’s lymphoma: a comprehensive study on the combined effects of MS1943 and Ibrutinib
Article in Frontiers in Oncology (September 2023)
The most recent citing publications are shown below. View all 31 publications that cite this research output on Dimensions.
Article in Frontiers in Oncology (September 2023)
Article in Journal of Biomolecular Structure and Dynamics (June 2023)
Article in Critical Reviews in Oncology/Hematology (November 2022)